³Ô¹ÏºÚÁÏÍø of the key themes driving M&A activity reveals that precision and personalized medicine accounted for four medical devices deals announced in Q3 2024, worth a total value of $146m. The $139m acquisition of Augmedix by Commure was the industry’s largest disclosed deal. GlobalData’s ³Ô¹ÏºÚÁÏÍøs Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry.
In value terms, precision and personalized medicine-related deal activity increased by 53% in Q3 2024 compared with the previous quarter’s total of $95.2m and rose by 589% as compared to Q3 2023. Related deal volume increased by 100% in Q3 2024 versus the previous quarter and was 100% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in 9M 2024 were Evercore; Jefferies Financial Group; Morgan Stanley with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in 9M 2024 were CMS Legal Services EEIG; John Wood Group; Kirkland & Ellis with 1, 1, 1 deals respectively.
For further understanding of GlobalData's ³Ô¹ÏºÚÁÏÍøs Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.